依普利酮治疗急性心肌梗死后心衰71例疗效观察(2)
 |
| 第1页 |
参见附件(1298KB，2页)。
[参考文献]
[1] 中华医学会心血管病分会,《中华心血管病杂志》编辑委员会,《中国循环杂志》编辑委员会.急性心肌梗死诊断和治疗指南[J]. 中华心血管杂志,2001,29(12):710-725.
[2] 孙艺红,方全. 心血管药物临床试验评价方法的建议[J]. 中华心血管病杂志,1998,26(1):21-23.
[3] Kobayashin,Yoshidak,Nakanos,et al. Cardioprotective mechnisnes of eplerenone on cardiac performance and remodling in failing rat hearts[J]. Hypertension,2006,47(4):671-679.
[4] Keidars,Gamlie-Lazarovicha,Kaplanm,et al. Minerallocorticoid receptor blocker increases angioensin-converting enzyme 2 activity in congestive heart failure patients[J]. Circ Res,2005,97(9):946-953.
[5] PittB,Remmew,Zannad F,et al. Eplerenone,a selective aldosterone blodeer,in patients with left ventricular dysfunction after myocardial infarction[J]. NengI J Med,2003,348(14):1309-1321.
[6] Antnan EM,Anbe DT,Arnstrong PW,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial in farction- executive summary.a report of the American College of Cardiology/Amer- ican Heart Association Task Force on Practice Guidelines(Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial In farction)[J]. Circalation,2004,110(5):588-636.
(收稿日期:2010-03-10)
您现在查看是摘要介绍页，详见PDF附件(1298KB，2页)。